Primitive origins of prostate cancer: In vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells

Molecular Oncology

Volumn 4, Issue 5, 2010, Pages 385-396

  Goldstein, Andrew S ^a   Stoyanova, Tanya ^a   Witte, O N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer initiation; Castration resistance; Prostate cancer; Stem cell; Tissue regeneration

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA1 INTEGRIN; KERATIN; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR;

APOPTOSIS; BIOLUMINESCENCE; CANCER GROWTH; CELL ACTIVITY; CELL DIFFERENTIATION; CELL POPULATION; COLONY FORMING CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW; STEM CELL; TISSUE REGENERATION;

EID: 77956615624     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.06.009     Document Type: Review

References (125)

1. Abrahamsson P.A. Neuroendocrine differentiation in prostatic carcinoma. Prostate 1999, 39:135-148.
2. Abrahamsson P.A., Falkmer S., Falt K., Grimelius L. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an " endocrine marker" Pathol. Res. Pract. 1989, 185:373-380.
3. Ahlgren G., Pedersen K., Lundberg S., Aus G., Hugosson J., Abrahamsson P.A. Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate 2000, 42:274-279.
4. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000, 404:193-197.
5. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
6. American Cancer Society What are the key statistics about prostate cancer? 2009, http://www.cancer.org/Cancer/ProstateCancer/DetailedGuide/prostate-cancer-key-statistics.
7. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., Hartley L., Robb L., Grosveld F.G., van der Wees J., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 2007, 9:201-209.
8. Aumuller G., Leonhardt M., Janssen M., Konrad L., Bjartell A., Abrahamsson P.A. Neurogenic origin of human prostate endocrine cells. Urology 1999, 53:1041-1048.
9. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
10. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
11. Belandia B., Powell S.M., Garcia-Pedrero J.M., Walker M.M., Bevan C.L., Parker M.G. Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol. Cell Biol. 2005, 25:1425-1436.
12. Berezovska O.P., Glinskii A.B., Yang Z., Li X.M., Hoffman R.M., Glinsky G.V. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle 2006, 5:1886-1901.
13. Bierie B., Nozawa M., Renou J.P., Shillingford J.M., Morgan F., Oka T., Taketo M.M., Cardiff R.D., Miyoshi K., Wagner K.U., et al. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene 2003, 22:3875-3887.
14. Blanpain C., Lowry W.E., Geoghegan A., Polak L., Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004, 118:635-648.
15. Bohrer M.H., Schmoll J. Immunohistochemical and morphometric studies on neuroendocrine differentiation of prostate carcinomas. Verh Dtsch Ges Pathol. 1993, 77:107-110.
16. Bonkhoff H., Stein U., Remberger K. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch. A Pathol. Anat. Histopathol 1993, 423:291-294.
17. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
18. Bui M., Reiter R.E. Stem cell genes in androgen-independent prostate cancer. Cancer Metastasis Rev. 1998, 17:391-399.
19. Burger P.E., Xiong X., Coetzee S., Salm S.N., Moscatelli D., Goto K., Wilson E.L. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc. Natl. Acad. Sci. USA 2005, 102:7180-7185.
20. Burger P.E., Gupta R., Xiong X., Ontiveros C.S., Salm S.N., Moscatelli D., Wilson E.L. High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 2009, 27:2220-2228.
21. Catz S.D., Johnson J.L. BCL-2 in prostate cancer: a minireview. Apoptosis 2003, 8:29-37.
22. Chan K.S., Espinosa I., Chao M., Wong D., Ailles L., Diehn M., Gill H., Presti J., Chang H.Y., van de Rijn M., et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. USA 2009.
23. Chen G., Shukeir N., Potti A., Sircar K., Aprikian A., Goltzman D., Rabbani S.A. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 2004, 101:1345-1356.
24. Collins A.T., Habib F.K., Maitland N.J., Neal D.E. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J. Cell Sci. 2001, 114:3865-3872.
25. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
26. Corey E., Quinn J.E., Buhler K.R., Nelson P.S., Macoska J.A., True L.D., Vessella R.L. LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate 2003, 55:239-246.
27. Cotsarelis G., Cheng S.Z., Dong G., Sun T.T., Lavker R.M. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 1989, 57:201-209.
28. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003, 17:3029-3035.
29. Cunha G.R., Lung B. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J. Exp. Zool. 1978, 205:181-193.
30. Dalrymple S., Antony L., Xu Y., Uzgare A.R., Arnold J.T., Savaugeot J., Sokoll L.J., De Marzo A.M., Isaacs J.T. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells. Cancer Res. 2005, 65:9269-9279.
31. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003, 17:1253-1270.
32. Dovey J.S., Zacharek S.J., Kim C.F., Lees J.A. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc. Natl. Acad. Sci. USA 2008, 105:11857-11862.
33. Eirew P., Stingl J., Raouf A., Turashvili G., Aparicio S., Emerman J.T., Eaves C.J. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat. Med. 2008, 14:1384-1389.
34. Ellis W.J., Vessella R.L., Buhler K.R., Bladou F., True L.D., Bigler S.A., Curtis D., Lange P.H. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin. Cancer Res. 1996, 2:1039-1048.
35. Ellwood-Yen K., Graeber T.G., Wongvipat J., Iruela-Arispe M.L., Zhang J., Matusik R., Thomas G.V., Sawyers C.L. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 2003, 4:223-238.
36. English H.F., Santen R.J., Isaacs J.T. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987, 11:229-242.
37. Epstein J.I. Prostatic ductal adenocarcinoma: a mini review. Med. Princ Pract. 2010, 19:82-85.
38. Garraway I.P., Sun W., Tran C.P., Perner S., Zhang B., Goldstein A.S., Hahm S.A., Haider M., Head C.S., Reiter R.E., et al. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 2009.
39. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
40. Glinsky G.V., Berezovska O., Glinskii A.B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 2005, 115:1503-1521.
41. Goldstein A.S., Lawson D.A., Cheng D., Sun W., Garraway I.P., Witte O.N. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc. Natl. Acad. Sci. USA 2008, 105:20882-20887.
42. Goldstein A.S., Huang J., Guo C., Garraway I.P., Witte O.N. Identification of a cell-of-origin for human prostate cancer. Science 2010, 329:568-571.
43. Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 2000, 2000(50):7-33.
44. Grisanzio C., Signoretti S. p63 in prostate biology and pathology. J. Cell Biochem. 2008, 103:1354-1368.
45. Gurel B., Iwata T., Koh C.M., Jenkins R.B., Lan F., Van Dang C., Hicks J.L., Morgan J., Cornish T.C., Sutcliffe S., et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod. Pathol. 2008, 21:1156-1167.
46. Hong K.U., Reynolds S.D., Watkins S., Fuchs E., Stripp B.R. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am. J. Pathol. 2004, 164:577-588.
47. Huang J., Yao J.L., di Sant'Agnese P.A., Yang Q., Bourne P.A., Na Y. Immunohistochemical characterization of neuroendocrine cells in prostate cancer. Prostate 2006, 66:1399-1406.
48. Huang J., Wu C., di Sant'Agnese P.A., Yao J.L., Cheng L., Na Y. Function and molecular mechanisms of neuroendocrine cells in prostate cancer. Anal. Quant Cytol. Histol. 2007, 29:128-138.
49. Huang J., Witte O.N. A seminal finding for prostate cancer?. N. Engl. J. Med. 2010, 362:175-176.
50. Huggins C. Endocrine control of prostatic cancer. Science 1943, 97:541-544.
51. Huggins C., Hodges C.V. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941, 1:293-297.
52. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., Rowan R., Amaral S., Curley D., Williams I.R., et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004, 6:587-596.
53. Hurt E.M., Kawasaki B.T., Klarmann G.J., Thomas S.B., Farrar W.L. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br. J. Cancer 2008, 98:756-765.
54. Isaacs J.T. Control of cell proliferation and cell death in the normal and neoplastic prostate: a stem cell model. Benign Prostatic Hyperplasia 1987, 85-94. National Institutes of Health, Bethesda, Maryland. C.H. Rodgers (Ed.).
55. Iwai N., Zhou Z., Roop D.R., Behringer R.R. Horizontal basal cells are multipotent progenitors in normal and injured adult olfactory epithelium. Stem Cells 2008, 26:1298-1306.
56. Jiborn T., Bjartell A., Abrahamsson P.A. Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment. Urology 1998, 51:585-589.
57. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007, 317:337.
58. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
59. Klein K.A., Reiter R.E., Redula J., Moradi H., Zhu X.L., Brothman A.R., Lamb D.J., Marcelli M., Belldegrun A., Witte O.N., Sawyers C.L. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med. 1997, 3:402-408.
60. Klezovitch O., Risk M., Coleman I., Lucas J.M., Null M., True L.D., Nelson P.S., Vasioukhin V. A causal role for ERG in neoplastic transformation of prostate epithelium. Proc. Natl. Acad. Sci. USA 2008, 105:2105-2110.
61. Korsten H., Ziel-van der Made A., Ma X., van der Kwast T., Trapman J. Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One 2009, 4:e5662.
62. Krijnen J.L., Janssen P.J., Ruizeveld de Winter J.A., van Krimpen H., Schroder F.H., van der Kwast T.H. Do neuroendocrine cells in human prostate cancer express androgen receptor?. Histochemistry 1993, 100:393-398.
63. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., Levine J.E., Wang J., Hahn W.C., Gilliland D.G., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006, 442:818-822.
64. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
65. Lawson D.A., Zong Y., Memarzadeh S., Xin L., Huang J., Witte O.N. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc. Natl. Acad. Sci. USA 2010, 107:2610-2615.
66. Lawson D.A., Xin L., Lukacs R.U., Cheng D., Witte O.N. Isolation and functional characterization of murine prostate stem cells. Proc. Natl. Acad. Sci. USA 2007, 104:181-186.
67. van Leenders G., Dijkman H., Hulsbergen-van de Kaa C., Ruiter D., Schalken J. Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab. Invest. 2000, 80:1251-1258.
68. van Leenders G.J., Dukers D., Hessels D., van den Kieboom S.W., Hulsbergen C.A., Witjes J.A., Otte A.P., Meijer C.J., Raaphorst F.M. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur. Urol. 2007, 52:455-463.
69. Leong K.G., Wang B.E., Johnson L., Gao W.Q. Generation of a prostate from a single adult stem cell. Nature 2008, 456:804-808.
70. Leong K.G., Gao W.Q. The Notch pathway in prostate development and cancer. Differentiation 2008, 76:699-716.
71. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., Asselin-Labat M.L., Gyorki D.E., Ward T., Partanen A., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913.
72. Lukacs R.U., Lawson D.A., Xin L., Zong Y., Garraway I., Goldstein A.S., Memarzadeh S., Witte O.N. Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harb Symp. Quant Biol. 2008, 73:491-502.
73. Ma X., Ziel-van der Made A.C., Autar B., van der Korput H.A., Vermeij M., van Duijn P., Cleutjens K.B., de Krijger R., Krimpenfort P., Berns A., et al. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res. 2005, 65:5730-5739.
74. McDonnell T.J., Troncoso P., Brisbay S.M., Logothetis C., Chung L.W., Hsieh J.T., Tu S.M., Campbell M.L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992, 52:6940-6944.
75. Morrison S.J., Uchida N., Weissman I.L. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 1995, 11:35-71.
76. Morrison S.J., Weissman I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994, 1:661-673.
77. Mulholland D.J., Cheng H., Reid K., Rennie P.S., Nelson C.C. The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli. J. Biol. Chem. 2002, 277:17933-17943.
78. Mulholland D.J., Xin L., Morim A., Lawson D., Witte O., Wu H. Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res. 2009, 69:8555-8562.
79. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
80. Okada H., Tsubura A., Okamura A., Senzaki H., Naka Y., Komatz Y., Morii S. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch. A Pathol. Anat. Histopathol 1992, 421:157-161.
81. Ontiveros C.S., Salm S.N., Wilson E.L. Axin2 expression identifies progenitor cells in the murine prostate. Prostate 2008, 68:1263-1272.
82. Palapattu G.S., Wu C., Silvers C.R., Martin H.B., Williams K., Salamone L., Bushnell T., Huang L.S., Yang Q., Huang J. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer. Prostate 2009, 69:787-798.
83. Passegue E., Wagner E.F., Weissman I.L. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 2004, 119:431-443.
84. Patrawala L., Calhoun T., Schneider-Broussard R., Li H., Bhatia B., Tang S., Reilly J.G., Chandra D., Zhou J., Claypool K., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
85. Patrawala L., Calhoun-Davis T., Schneider-Broussard R., Tang D.G. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res. 2007, 67:6796-6805.
86. Pereira D.S., Dorrell C., Ito C.Y., Gan O.I., Murdoch B., Rao V.N., Zou J.P., Reddy E.S., Dick J.E. Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc. Natl. Acad. Sci. USA 1998, 95:8239-8244.
87. Pinthus J.H., Waks T., Schindler D.G., Harmelin A., Said J.W., Belldegrun A., Ramon J., Eshhar Z. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. Cancer Res. 2000, 60:6563-6567.
88. Prat A., Perou C.M. Mammary development meets cancer genomics. Nat. Med. 2009, 15:842-844.
89. Pretlow T.G., Wolman S.R., Micale M.A., Pelley R.J., Kursh E.D., Resnick M.I., Bodner D.R., Jacobberger J.W., Delmoro C.M., Giaconia J.M., et al. Xenografts of primary human prostatic carcinoma. J. Natl. Cancer Inst. 1993, 85:394-398.
90. Pretlow T.G., Schwartz S., Giaconia J.M., Wright A.L., Grimm H.A., Edgehouse N.L., Murphy J.R., Markowitz S.D., Jamison J.M., Summers J.L., et al. Prostate cancer and other xenografts from cells in peripheral blood of patients. Cancer Res. 2000, 60:4033-4036.
91. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
92. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
93. Reynolds B.A., Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 1996, 175:1-13.
94. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 2004, 117:3539-3545.
95. Robinson E.J., Neal D.E., Collins A.T. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 1998, 37:149-160.
96. Rock J.R., Onaitis M.W., Rawlins E.L., Lu Y., Clark C.P., Xue Y., Randell S.H., Hogan B.L. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl. Acad. Sci. USA 2009, 106:12771-12775.
97. di Sant'Agnese P.A. Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol. 1992, 23:287-296.
98. Scher H.I., Sawyers C.L. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J. Clin. Oncol. 2005, 23:8253-8261.
99. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
100. Shi X., Gipp J., Bushman W. Anchorage-independent culture maintains prostate stem cells. Dev. Biol. 2007, 312:396-406.
101. Shou J., Ross S., Koeppen H., de Sauvage F.J., Gao W.Q. Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res. 2001, 61:7291-7297.
102. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
103. So C.W., Karsunky H., Passegue E., Cozzio A., Weissman I.L., Cleary M.L. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell 2003, 3:161-171.
104. Stingl J., Eaves C.J., Kuusk U., Emerman J.T. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 1998, 63:201-213.
105. Stingl J., Eaves C.J., Zandieh I., Emerman J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 2001, 67:93-109.
106. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
107. Tomlins S.A., Laxman B., Dhanasekaran S.M., Helgeson B.E., Cao X., Morris D.S., Menon A., Jing X., Cao Q., Han B., et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007, 448:595-599.
108. Tsujimura A., Koikawa Y., Salm S., Takao T., Coetzee S., Moscatelli D., Shapiro E., Lepor H., Sun T.T., Wilson E.L. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J. Cell Biol. 2002, 157:1257-1265.
109. Vander Griend D.J., Karthaus W.L., Dalrymple S., Meeker A., DeMarzo A.M., Isaacs J.T. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res. 2008, 68:9703-9711.
110. Verhagen A.P., Ramaekers F.C., Aalders T.W., Schaafsma H.E., Debruyne F.M., Schalken J.A. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 1992, 52:6182-6187.
111. Wainstein M.A., He F., Robinson D., Kung H.J., Schwartz S., Giaconia J.M., Edgehouse N.L., Pretlow T.P., Bodner D.R., Kursh E.D., et al. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res. 1994, 54:6049-6052.
112. Wang S., Garcia A.J., Wu M., Lawson D.A., Witte O.N., Wu H. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc. Natl. Acad. Sci. USA 2006, 103:1480-1485.
113. Wang X.D., Leow C.C., Zha J., Tang Z., Modrusan Z., Radtke F., Aguet M., de Sauvage F.J., Gao W.Q. Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev. Biol. 2006, 290:66-80.
114. Wang X., Kruithof-de Julio M., Economides K.D., Walker D., Yu H., Halili M.V., Hu Y.P., Price S.M., Abate-Shen C., Shen M.M. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009, 461:495-500.
115. Wang Z., Li Y., Banerjee S., Kong D., Ahmad A., Nogueira V., Hay N., Sarkar F.H. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J. Cell Biochem. 2010.
116. Williams R.T., den Besten W., Sherr C.J. Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia. Genes Dev. 2007, 21:2283-2287.
117. Xin L., Ide H., Kim Y., Dubey P., Witte O.N. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc. Natl. Acad. Sci. USA 2003, 100(Suppl. 1):11896-11903.
118. Xin L., Lawson D.A., Witte O.N. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc. Natl. Acad. Sci. USA 2005, 102:6942-6947.
119. Xin L., Lukacs R.U., Lawson D.A., Cheng D., Witte O.N. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 2007, 25:2760-2769.
120. Yang F., Li X., Sharma M., Sasaki C.Y., Longo D.L., Lim B., Sun Z. Linking beta-catenin to androgen-signaling pathway. J. Biol. Chem. 2002, 277:11336-11344.
121. Yoshimoto M., Cutz J.C., Nuin P.A., Joshua A.M., Bayani J., Evans A.J., Zielenska M., Squire J.A. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet. Cytogenet. 2006, 169:128-137.
122. Zhang Y., Wang Z., Ahmed F., Banerjee S., Li Y., Sarkar F.H. Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells. Int. J. Cancer 2006, 119:2071-2077.
123. Zhao C., Blum J., Chen A., Kwon H.Y., Jung S.H., Cook J.M., Lagoo A., Reya T. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12:528-541.
124. Zhu L., Gibson P., Currle D.S., Tong Y., Richardson R.J., Bayazitov I.T., Poppleton H., Zakharenko S., Ellison D.W., Gilbertson R.J. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607.
125. Zong Y., Xin L., Goldstein A.S., Lawson D.A., Teitell M.A., Witte O.N. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc. Natl. Acad. Sci. USA 2009, 106:12465-12470.